dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahadue, FL; Soll, R | 1 |
| Cotton, R; Guthrie, R; Hirata, T; LeBlanc, M; Long, W; Mammel, M; Sell, M | 1 |
| Bard, H; Derleth, D; Long, W; Pauly, T; Robertson, C; Sauve, R; Stevenson, D; Vincer, M | 1 |
| Anzueto, A; Barrett, J; Colice, G; Engle, M; Jubran, A; Ohar, JA; Pattishall, EN; Perret, KA; Piquette, CA; Rennard, SI; Rubin, BK | 1 |
| Nightingale, SL | 1 |
1 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Chronic Disease
| Article | Year |
|---|---|
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Lung Diseases; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Time Factors | 2012 |
4 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Chronic Disease
| Article | Year |
|---|---|
One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Hospitalization; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Neurologic Examination; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Child Development; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Lung Diseases; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1995 |
A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Topics: Biological Products; Chronic Disease; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Male; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Risk | 1996 |
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.
Topics: Administration, Intranasal; Aerosols; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Male; Middle Aged; Mucociliary Clearance; Nebulizers and Vaporizers; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Function Tests; Sputum; Statistics, Nonparametric | 1997 |
1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Chronic Disease
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Chronic Disease; Diet Fads; Dietary Fiber; Drug Combinations; Esophageal Stenosis; Fatty Alcohols; Fentanyl; Galactans; Humans; Infant, Low Birth Weight; Infant, Newborn; Mannans; Pain; Phosphorylcholine; Plant Gums; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; United States; United States Food and Drug Administration | 1990 |